Holista Colltech Limited (ASX:HCT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0650
+0.0030 (4.84%)
At close: Mar 6, 2026
116.67%
Market Cap 23.91M
Revenue (ttm) 5.76M
Net Income (ttm) -948.92K
Shares Out 367.83M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 222,480
Average Volume 52,746
Open 0.0620
Previous Close 0.0620
Day's Range 0.0620 - 0.0700
52-Week Range 0.0210 - 0.1100
Beta 1.27
RSI 31.78
Earnings Date Feb 26, 2026

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemi... [Read more]

Industry Packaged Foods
CEO Leong Loong
Employees 58
Stock Exchange Australian Securities Exchange
Ticker Symbol HCT
Full Company Profile

Financial Performance

In 2025, Holista Colltech's revenue was 5.79 million, an increase of 3.44% compared to the previous year's 5.60 million. Losses were -948,921, 1026.8% more than in 2024.

Financial Statements

News

There is no news available yet.